
GTBP
Healthcare · Biotechnology · $7.7M market cap
$3.72-0.12 (-3.1%)Nov 13, 4:00 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now · -25.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 13, 2026 | Time not confirmed | -2.50 | — | — |
| Aug 14, 2026 | Before the open | -0.08 | -0.12 | -50.0% |
| May 15, 2026 | Before the open | -0.08 | -0.11 | -37.5% |
| Mar 2, 2026 | Time not confirmed | -5.50 | -121.00 | -2100.0% |
| Nov 14, 2025 | After the close | -0.38 | -0.83 | -118.4% |
| Aug 14, 2025 | After the close | -0.68 | -0.55 | +19.1% |
| May 15, 2025 | After the close | -0.64 | -0.76 | -18.8% |
| Feb 21, 2025 | After the close | -1.55 | -1.66 | -7.1% |
| Nov 14, 2024 | After the close | -2.70 | -1.53 | +43.3% |
| Aug 14, 2024 | After the close | -2.70 | -2.17 | +19.7% |
| May 15, 2024 | After the close | -2.70 | -1.64 | +39.3% |
| Mar 26, 2024 | After the close | -2.70 | -2.19 | +18.9% |
| Nov 1, 2023 | Before the open | -3.30 |
GT Biopharma, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of immuno-oncology products based on its Tri-specific Killer Engager (TriKE) and Tetra-specific Killer Engager (Dual Targeting TriKE) platforms. It develops GTB-3650, which is in phase 1 trials that target CD33 on the surface of myeloid leukemias and an agonistic camelid; GTB-5550, that is in phase 1…
| -2.13 |
| +35.5% |
| Aug 7, 2023 | Before the open | -3.60 | -2.54 | +29.4% |
| May 15, 2023 | After the close | -4.35 | -2.85 | +34.5% |
| Mar 30, 2023 | After the close | -0.17 | -0.18 | -5.9% |
| Oct 31, 2022 | After the close | -3.30 | -6.61 | -100.3% |
| Aug 15, 2022 | Before the open | -5.40 | -2.86 | +47.0% |
| May 16, 2022 | Before the open | -0.31 | -0.17 | +45.2% |
| Mar 28, 2022 | After the close | -6.30 | -15.76 | -150.2% |
| Nov 10, 2021 | After the close | -7.05 | -5.69 | +19.3% |
| Aug 23, 2021 | After the close | -7.65 | -3.92 | +48.8% |
| May 17, 2021 | After the close | -9.90 | -54.90 | -454.5% |
| Nov 13, 2020 | After the close | — | -0.04 | — |
| Aug 14, 2020 | After the close | — | -0.12 | — |
| May 15, 2020 | After the close | — | -0.02 | — |
| Mar 27, 2020 | After the close | — | -0.02 | — |
| Nov 14, 2019 | After the close | — | -0.51 | — |
| Aug 14, 2019 | After the close | — | -0.05 | — |
| May 15, 2019 | After the close | — | -0.09 | — |
| Mar 29, 2019 | After the close | — | -0.08 | — |
| Nov 15, 2018 | Time not confirmed | — | -4.70 | — |
| Aug 14, 2018 | Time not confirmed | — | -0.18 | — |
| May 15, 2018 | Time not confirmed | — | -0.20 | — |
| Feb 28, 2018 | Time not confirmed | — | -0.12 | — |